Production (Stage)
GRI Bio, Inc.
GRI
$1.32
-$0.04-2.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.68% | 37.05% | 37.88% | 28.12% | -152.15% |
| Total Depreciation and Amortization | -1,816.67% | -2,600.00% | -163.64% | -85.71% | -88.24% |
| Total Amortization of Deferred Charges | -- | -- | -100.00% | -100.00% | -31.57% |
| Total Other Non-Cash Items | 34.88% | -25.10% | -116.67% | -81.08% | -22.59% |
| Change in Net Operating Assets | 7.10% | -126.67% | -162.81% | -153.95% | -44.97% |
| Cash from Operations | 23.27% | 4.22% | -184.79% | -263.18% | -570.08% |
| Capital Expenditure | -- | -- | 100.00% | 100.00% | -166.67% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 100.00% | 100.00% | -166.67% |
| Total Debt Issued | -- | -- | -100.00% | -100.00% | -100.00% |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | 100.00% |
| Issuance of Common Stock | -52.91% | 13.07% | -6.31% | -14.70% | -- |
| Repurchase of Common Stock | -- | -- | 99.19% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 70.68% | 24.98% | 128.94% | 134.39% | -935.10% |
| Cash from Financing | -48.54% | 9.58% | 75.12% | 61.86% | 603.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -122.31% | 78.99% | -62.83% | -67.56% | 725.23% |